ESSEN SUPPLEMENTS | INTEGRATED PROTEIN | ESSEN SUPPLEMENTS/ INTEGRATED PROTEIN |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -192.5 | 101.9 | - | View Chart |
P/BV | x | 0.9 | 1.6 | 56.0% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ESSEN SUPPLEMENTS Mar-21 |
INTEGRATED PROTEIN Mar-21 |
ESSEN SUPPLEMENTS/ INTEGRATED PROTEIN |
5-Yr Chart Click to enlarge
|
||
High | Rs | 18 | 4 | 512.5% | |
Low | Rs | 5 | 2 | 224.3% | |
Sales per share (Unadj.) | Rs | 0 | 0 | - | |
Earnings per share (Unadj.) | Rs | 0.6 | 0.1 | 890.1% | |
Cash flow per share (Unadj.) | Rs | 0.6 | 0.2 | 373.8% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 20.3 | 7.7 | 265.5% | |
Shares outstanding (eoy) | m | 9.81 | 3.20 | 306.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 0 | - | |
Avg P/E ratio | x | 20.0 | 43.9 | 45.7% | |
P/CF ratio (eoy) | x | 20.0 | 18.6 | 107.5% | |
Price / Book Value ratio | x | 0.6 | 0.4 | 151.5% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 115 | 9 | 1,232.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 0 | 140.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 0 | - | |
Other income | Rs m | 24 | 2 | 1,512.5% | |
Total revenues | Rs m | 24 | 2 | 1,512.5% | |
Gross profit | Rs m | -18 | -1 | 1,810.8% | |
Depreciation | Rs m | 0 | 0 | 0.0% | |
Interest | Rs m | 0 | 0 | - | |
Profit before tax | Rs m | 6 | 0 | 1,975.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 0 | 0.0% | |
Profit after tax | Rs m | 6 | 0 | 2,728.6% | |
Gross profit margin | % | 0 | 0 | - | |
Effective tax rate | % | 0 | 25.7 | -0.1% | |
Net profit margin | % | 0 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 39 | 2 | 1,954.5% | |
Current liabilities | Rs m | 38 | 1 | 4,412.8% | |
Net working cap to sales | % | 0 | 0 | - | |
Current ratio | x | 1.0 | 2.3 | 44.3% | |
Inventory Days | Days | 0 | 0 | - | |
Debtors Days | Days | 0 | 0 | - | |
Net fixed assets | Rs m | 198 | 24 | 824.9% | |
Share capital | Rs m | 98 | 35 | 278.7% | |
"Free" reserves | Rs m | 102 | -11 | -950.5% | |
Net worth | Rs m | 200 | 25 | 814.0% | |
Long term debt | Rs m | 0 | 0 | 0.0% | |
Total assets | Rs m | 238 | 26 | 912.6% | |
Interest coverage | x | 0 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0 | 0 | - | |
Return on assets | % | 2.4 | 0.8 | 296.2% | |
Return on equity | % | 2.9 | 0.9 | 332.1% | |
Return on capital | % | 2.9 | 1.2 | 249.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -23 | -1 | 2,522.8% | |
From Investments | Rs m | 27 | NA | 11,137.5% | |
From Financial Activity | Rs m | -3 | NA | -997.1% | |
Net Cashflow | Rs m | 0 | 0 | -38.2% |
Indian Promoters | % | 74.6 | 46.2 | 161.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.1 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 25.4 | 53.8 | 47.2% | |
Shareholders | 968 | 1,666 | 58.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ESSEN SUPPLEMENTS With: VA TECH WABAG TEAMLEASE SERVICES SIS SUN PHARMA ADV. RES. DELTA CORP
On Tuesday, Indian share markets ended on a firm note as fag-end buying in Reliance Industries and other index heavyweight stocks pushed benchmark indices higher.